Literature DB >> 30272570

Methodological considerations for large-scale breath analysis studies: lessons from the U-BIOPRED severe asthma project.

Waqar M Ahmed1, Paul Brinkman, Hans Weda, Hugo H Knobel, Yun Xu, Tamara M Nijsen, Royston Goodacre, Nicholas Rattray, Teunis J Vink, Marco Santonico, Giorgio Pennazza, Paolo Montuschi, Peter J Sterk, Stephen J Fowler.   

Abstract

Methods for breath sampling and analysis require robust quality assessment to minimise the risk of false discoveries. Planning large-scale multi-site breath metabolite profiling studies also requires careful consideration of systematic and random variation as a result of sampling and analysis techniques. In this study we use breath sample data from the recent U-BIOPRED cohort to evaluate and discuss some important methodological considerations such as batch variation and correction, variation between sites, storage and transportation, as well as inter-instrument analytical differences. Based on this we provide a summary of recommended best practices for new large scale multi-site studies.

Mesh:

Substances:

Year:  2018        PMID: 30272570     DOI: 10.1088/1752-7163/aae557

Source DB:  PubMed          Journal:  J Breath Res        ISSN: 1752-7155            Impact factor:   3.262


  6 in total

1.  Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver disease.

Authors:  Rohit Sinha; Khalida A Lockman; Natalie Z M Homer; Edward Bower; Paul Brinkman; Hugo H Knobel; Jonathan A Fallowfield; Alan J Jaap; Peter C Hayes; John N Plevris
Journal:  JHEP Rep       Date:  2020-06-15

2.  Assessment of pulmonary oxygen toxicity in special operations forces divers under operational circumstances using exhaled breath analysis.

Authors:  Thijs T Wingelaar; Paul Brinkman; Rigo Hoencamp; Pieter-Jan Am van Ooij; Anke-Hilse Maitland-van der Zee; Markus W Hollmann; Rob A van Hulst
Journal:  Diving Hyperb Med       Date:  2020-03-31       Impact factor: 0.887

Review 3.  Toward a Standardized Strategy of Clinical Metabolomics for the Advancement of Precision Medicine.

Authors:  Nguyen Phuoc Long; Tran Diem Nghi; Yun Pyo Kang; Nguyen Hoang Anh; Hyung Min Kim; Sang Ki Park; Sung Won Kwon
Journal:  Metabolites       Date:  2020-01-29

Review 4.  Breath Biopsy and Discovery of Exclusive Volatile Organic Compounds for Diagnosis of Infectious Diseases.

Authors:  José E Belizário; Joel Faintuch; Miguel Garay Malpartida
Journal:  Front Cell Infect Microbiol       Date:  2021-01-07       Impact factor: 5.293

5.  Breath and plasma metabolomics to assess inflammation in acute stroke.

Authors:  Waqar Ahmed; Iain R White; Maxim Wilkinson; Craig F Johnson; Nicholas Rattray; Amit K Kishore; Royston Goodacre; Craig J Smith; Stephen J Fowler
Journal:  Sci Rep       Date:  2021-11-09       Impact factor: 4.379

6.  Breath volatile organic compounds and inflammatory markers in adult asthma patients: negative results from the ALLIANCE cohort.

Authors:  Olaf Holz; Benjamin Waschki; Henrik Watz; Anne Kirsten; Mustafa Abdo; Frauke Pedersen; Markus Weckmann; Oliver Fuchs; Anna-Maria Dittrich; Gesine Hansen; Matthias V Kopp; Erika von Mutius; Klaus F Rabe; Jens M Hohlfeld; Thomas Bahmer
Journal:  Eur Respir J       Date:  2021-02-11       Impact factor: 16.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.